Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCB0022 in Advanced Parkinson's Disease
NCT06055985Phase 2Completed
- Sponsor
- UCB
- Start
- Nov 2023
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glovadalen in Parkinson's disease (PD), sponsored by UCB. Started Nov 2023; status: completed.
02
Drugs
glovadalen
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06055985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06055985.